Advertisement

Reactions Weekly

, Volume 1761, Issue 1, pp 302–302 | Cite as

Pembrolizumab/secukinumab

Psoriasiform skin reaction and thrombocytopenia: case report
Case report

Reference

  1. Johnson D, et al. IL17A blockade successfully treated psoriasiform dermatologic toxicity from immunotherapy. Cancer Immunology Research 7: 860-865, No. 6, Jun 2019. Available from: URL: http://doi.org/10.1158/2326-6066.CIR-18-0682 - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations